{
    "paper_id": "485",
    "score": 4,
    "summary": "In this context, 2-ethylhexan-1-ol is identified as one of the metabolites present in malignant effusion samples, showing a significant fold change compared to benign samples. This indicates that 2-ethylhexan-1-ol is likely involved in the metabolic processes associated with malignancy, highlighting its potential as a biomarker for distinguishing between malignant and benign conditions. The relationship is underscored by the statistical significance of its concentration differences in the two groups."
}